已收盤 08-07 16:00:00 美东时间
+0.260
+6.30%
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
Benchmark analyst Michael Rindos maintains AGNT (NASDAQ:AGNT) with a Buy and lowers the price target from $8 to $6.
08-06 03:02
eXp World Holdings (NASDAQ:AGNT) sees Q3 sales of $1.350 billion-$1.450 billion vs $1.369 billion analyst estimate.
08-05 04:26
eXp World Holdings (NASDAQ:AGNT) affirms FY2026 sales outlook from $4.850 billion-$5.150 billion to $4.850 billion-$5.150 billion vs $5.001 billion estimate.
08-05 04:26
eXp World Holdings (NASDAQ:AGNT) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.02 by 200 percent. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $1.449 billion ...
08-05 04:04
DA Davidson analyst Tom White downgrades AGNT (NASDAQ:AGNT) from Buy to Neutral and lowers the price target from $10.25 to $6.5.
07-02 18:37
eXp World Holdings ( ($AGNT) ) has provided an announcement. On June 11, 2026, ...
06-12 00:21
AGNT, Inc. (formerly eXp World Holdings, Inc.) has completed its corporate transformation, renaming itself and redomesticating to Texas. The change reflects the company's focus on agents, aligning its legal identity with its agent-centric mission. AGNT now operates as a multi-model platform, uniting brands like eXp Realty, NextHome, and FrameVR.io under a single structure. The move to Texas supports a governance framework that considers agents' i...
06-11 16:00
eXp World Holdings management will participate in the D.A. Davidson 2026 Technology & Consumer Conference on June 11, 2026, at the Four Seasons Hotel in Nashville, Tennessee. They will host one-on-one investor meetings without any formal presentation or webcast. Interested institutional investors and conference attendees can request meetings through the conference portal, contact D.A. Davidson representatives, or reach out to eXp World Holdings' ...
05-27 16:15
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46